The sector of stem cell therapy is experiencing rapid growth, attracting both significant investment and heightened public interest. This multifaceted financial landscape is defined by a spectrum of variables, including legal frameworks, clinical trial costs, and the evolving demands of the consumer base. Deciphering this terrain is essential for b

Glaucoma, a condition that damages the optic nerve and can lead to vision loss, often requires surgical intervention. Fortunately, minimally invasive glaucoma surgery (MIGS) offers a less disruptive alternative to traditional procedures. These techniques involve small incisions and minimal tissue manipulation, resulting in quicker recovery times, r